Ó£»¨ÊÓÆµ

Skip to main content

Table 4 OR and 95% CI for changes in SUA for high diastolic blood pressure incidence

From: Gender-specific association between serum uric acid levels and hypertension in East China: a cross-sectional study

Ìý

Model 1

Model 2

Model 3

Model 4

Model 5

Variable

OR, 95% CI

P Value

OR, 95% CI

P Value

OR, 95% CI

P Value

OR, 95% CI

P Value

OR, 95% CI

P Value

Males

ÌýÌýÌýÌýÌýÌýÌýÌýÌýÌý

 Q1

1.00 (ref)

-

1.00 (ref)

-

1.00 (ref)

-

1.001

0.05

1.07

0.05

 Q2

1.10 (0.95, 1.28)

0.201

1.06 (0.91, 1.23)

0.4801

1.08 (0.92, 1.26)

0.3332

(1.000, 1.001)

(1.00, 1.13)

 Q3

1.35 (1.17, 1.55)

&±ô³Ù; 0.0001**

1.16 (1.00, 1.35)

0.0493*

1.18 (1.01, 1.38)

0.0354

ÌýÌý

 Q4

1.62 (1.41, 1.86)

&±ô³Ù; 0.0001**

1.14 (0.98, 1.34)

0.0931

1.15 (0.98, 1.34)

0.0982

ÌýÌý

p for trend

&±ô³Ù; 0.0001**

Ìý

0.054

Ìý

0.0659

ÌýÌýÌýÌýÌý

Female

ÌýÌýÌýÌýÌýÌýÌýÌýÌýÌý

 Q1

1.00 (ref)

-

1.00 (ref)

-

1.00 (ref)

-

1

0.6123

0.97

0.6123

 Q2

1.01 (0.77, 1.32)

0.9342

0.87 (0.66, 1.14)

0.3212

0.91 (0.69, 1.20)

0.4978

(0.998, 1.001)

(0.84, 1.11)

 Q3

1.11 (0.86, 1.44)

0.4286

0.79 (0.60, 1.03)

0.0853

0.83 (0.63, 1.09)

0.1761

ÌýÌý

 Q4

1.73 (1.36, 2.20)

&±ô³Ù; 0.0001**

0.83 (0.64, 1.08)

0.1733

0.89 (0.68, 1.18)

0.421

ÌýÌý

p for trend

&±ô³Ù; 0.0001**

Ìý

0.1653

Ìý

0.3843

ÌýÌýÌýÌýÌý

Total

ÌýÌýÌýÌýÌýÌýÌýÌýÌýÌý

 Q1

1.00 (ref)

-

1.00 (ref)

-

1.00 (ref)

-

1.001

0.0569

1.057

0.0569

 Q2

1.55 (1.33, 1.80)

&±ô³Ù; 0.0001**

0.98 (0.83, 1.15)

0.7999

0.99 (0.84, 1.17)

0.9199

(1.000, 1.001)

(0.998, 1.119)

 Q3

2.51 (2.17, 2.89)

&±ô³Ù; 0.0001**

1.01 (0.86, 1.20)

0.8913

1.04 (0.88, 1.24)

0.6496

ÌýÌý

 Q4

3.89 (3.39, 4.45)

&±ô³Ù; 0.0001**

1.10 (0.93, 1.32)

0.2704

1.13 (0.95, 1.36)

0.1751

ÌýÌý

p for trend

&±ô³Ù; 0.0001**

Ìý

0.1198

Ìý

0.0753

ÌýÌýÌýÌýÌý
  1. Notes: Serum uric acid quartiles (Q1–Q4) in men (Q1: ≤ 346.70; Q2: 346.70–395.30; Q3: 395.30–448.70; and Q4: > 448.70 µ mol/L). In women (Q1: ≤ 244.50; Q2: 244.50–281.10; Q3: 281.10–320.80; and Q4: > 320.80 µ mol/L). In total population (Q1: ≤ 278.30; Q2: 278.30–338.60; Q3: 338.60–407.20; and Q4: > 407.20 µ mol/L). BMI, body mass index; FBG, fasting blood glucose; eGFR, estimated glomerular filtration rate; TG, triglycerides; TC, total cholesterol; LDL, low density lipoprotein; HDL, high density lipoprotein
  2. Model 1: Unadjusted
  3. Model 2: Adjusted for age, gender, BMI, FBG, diabetes, TG, TC, LDL, and HDL
  4. Model 3: Adjusted for age, gender, BMI, FBG, diabetes, TG, TC, LDL, HDL, pulse and eGFR
  5. Model 4: Serum uric acid (µ mol/L) as continuous variable. Adjusted for age, gender, BMI, FBG, diabetes, TG, TC, LDL, HDL, pulse and eGFR
  6. Model 5: Serum uric acid (mg/dL) as continuous variable. Adjusted for age, gender, BMI, FBG, diabetes, TG, TC, LDL, HDL, pulse and eGFR
  7. No adjustment for gender in men and women
  8. *P Value < 0.05
  9. **P Value < 0.0001